查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954583

全球排卵測試盒市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析、未來預測（2026-2034）

Ovulation Testing Kits Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 請詢問到貨日

價格

排卵測試盒市場成長驅動因素

2025年全球排卵測試盒市場規模為2.664億美元，預計將從2026年的2.829億美元成長到2034年的4.897億美元，預測期內（2026-2034年）年複合成長率為7.10%。北美地區在2025年將以74.20%的市場佔有率領跑，這主要歸功於多囊性卵巢症候群（PCOS）的高發生率、人們對生殖健康的重視以及家用檢測解決方案的廣泛應用。

排卵測試盒是女性追蹤月經週期並確定排卵期的診斷工具。這些測試盒通常透過檢測黃體生成素（LH）或黃體素代謝物的高峰來幫助女性更有效地規劃懷孕。它們廣泛用於排卵不規則的女性，尤其是患有PCOS的女性。

新冠疫情的影響

在2020年新冠疫情期間，由於供應鏈中斷、產品供應有限以及婦科就診量減少，市場保持了溫和成長。然而，在2020年下半年，隨著消費者越來越傾向於居家不孕症監測解決方案，市場需求顯著回升。這種向自我檢測和遠距醫療輔助診斷的轉變對市場的長期成長產生了積極影響。

市場趨勢

對新產品發布和合作關係的關注度提高

隨著人們對多囊性卵巢症候群（PCOS）和生育力追蹤的認識不斷提高，各公司加速推出創新產品。市場參與者增加數位化、可連接應用程式的排卵測試盒的數量，這些測試盒準確、快速且易於解讀。

例如，2023年5月，Fridababy, LLC推出了一系列新的生育治療產品，包括排卵預測測試和排卵/妊娠追蹤套裝。同樣，在2023年7月，Proov與Quest Diagnostics Incorporated合作，擴大其家用生育力檢測測試盒Confirm PdG的覆蓋範圍。這些舉措提高產品的可及性，並加速其在全球的普及。

市場成長因素

多囊性卵巢症候群（PCOS）發生率上升

多囊性卵巢症候群（PCOS）是一種影響育齡女性的主要荷爾蒙失調疾病，通常會導致月經週期不規則和不孕症。根據世界衛生組織（WHO）（2023年6月）的資料，多囊性卵巢症候群（PCOS）影響全球約8-13%的女性，是導致不孕的主要原因之一。

在印度，根據美國國家生物技術資訊中心（NCBI）（2022年）的報告，根據雄性激素過多研究協會（AES）的調查，15-45歲女性中PCOS的盛行率約為10%；而根據美國國立衛生研究院（NIH）的調查，這一比例為5.8%。盛行率的上升是推動排卵測試盒需求成長的主要動力。

此外，排卵測試盒具有很高的準確性。根據 Cloudnine Fertility（2022年 11月）的資料，排卵預測測試盒的準確率約為 97%，這進一步推動了其普及。

限制

臨床限制與假陽性風險

儘管排卵測試盒有很多優點，但它們也存在一些限制。根據 Dotdash Meredith（2023年 6月）發布的公告，排卵測試盒與激素類避孕藥、促排卵藥物和四環素類抗生素等藥物合用時，可能會產生不準確的結果。

此外，雖然排卵測試盒可以以高達 99%的準確率檢測到 LH 峰值，但它們不能確認排卵或保證懷孕。這些測試盒只能追蹤排卵，無法偵測卵子活力，這項限制可能會阻礙其廣泛應用。

市場區隔分析

依裝置類型

市場依設備類型細分為數位設備、線指示設備和顯微鏡設備。

  • 預計到2026年，數位設備細分市場將佔據89.57%的市場佔有率，這主要得益於其高精度、快速出結果、可靠性和易用性。 線指示設備細分市場預計將實現最高的年複合成長率，這主要歸功於其價格實惠且適合家庭使用。 顯微鏡設備細分市場預計將保持穩定成長，這主要得益於其可重複使用性和長期可用性。

依樣本類型劃分

依樣本類型，市場分為血液、尿液和唾液三大類。

  • 預計到2026年，血液樣本將佔據市場主導地位，市場佔有率高達 89.15%，這主要得益於其高精度以及與行動應用程式整合，便於結果追蹤。
  • 由於新產品不斷湧現，例如 Ro 公司於2020年 6月推出的尿液 LH 檢測套裝，尿液樣本預計將實現顯著成長。

依最終使用者劃分

依最終用戶劃分，市場可分為生育中心、醫院和診所等機構。

  • 預計到2026年，生育治療中心將成為市場佔有率最大的細分市場，市場佔有率達到 57.72%，這主要得益於全球生育治療診所數量的不斷成長。
  • 隨著患者越來越傾向於選擇集檢測和治療於一體的醫療機構，醫院和診所領域預計將迎來顯著成長。

區域概覽

北美

北美在2025年佔了最大的市場佔有率（74.20%）。受多囊性卵巢症候群（PCOS）高發生率和人們對生育力檢測的高度關注的推動，該地區的市場規模預計將在2026年達到2.104億美元。

歐洲

歐洲佔據了較大的市場佔有率，這得益於Geratherm Medical AG和SPD Swiss Precision Diagnostics GmbH等主要公司的存在。該地區的優勢在於其先進的醫療基礎設施和生育治療的廣泛應用。

亞太地區

由於中國和印度不孕症病例數量不斷增加、人們的意識不斷提高以及數位醫療解決方案的普及，預計亞太地區在預測期內將實現顯著成長。

世界其他地區

由於全球製造商持續進入尚未開發的市場，預計其他區域市場也將穩定成長。

主要公司

市場上主要的公司包括：

  • Piramal Pharma Ltd.
  • Geratherm Medical AG
  • SPD Swiss Precision Diagnostics GmbH
  • The Boots Company PLC
  • Proov
  • Ro
  • Wondfo
  • Everly Health, Inc.
  • Alfa Scientific Designs, Inc.
  • AdvaCare Pharma

這些各公司致力於併購、業務合作和產品創新，以鞏固其市場地位。

產業主要動態

  • 2023年7月：Proov與2SAN GLOBAL LIMITED達成經銷協議，擴大其在美國的產品分銷。
  • 2023年5月：Frida Baby宣布推出全新生育治療產品系列。
  • 2022年1月：Kindbody推出 "Kind at Home" 生育力檢測套裝。
  • 2021年5月：Ro收購Modern Fertility，拓展其生育治療產品線。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 主要國家和地區女性不孕症盛行率（2025年）
  • 新產品發布
  • 主要產業趨勢：併購、業務合作等
  • 新冠疫情對市場的影響

第5章 全球排卵測試盒市場分析：洞察與展望預測（2021-2034）

  • 市場分析、洞察與預測：依設備類型劃分
    • 線指示器設備
    • 數位設備
    • 顯微鏡設備
  • 市場分析、洞察與預測：依樣本類型劃分
    • 尿液
    • 血液
    • 唾液
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院和診所
    • 生育中心
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 世界其他地區

第6章 北美排卵測試測試盒市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲排卵測試盒市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他歐洲國家

第8章 亞太地區排卵測試盒市場分析：洞察與預測（2021-2034）

  • 國家細分
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 其他亞洲國家太平洋

第9章 其他地區（ROW）排卵測試測試盒市場分析：洞察與預測（2021-2034）

第10章 競爭分析

  • 全球市場佔有率分析（2025）
  • 公司簡介
    • Piramal Pharma Ltd.
    • Geratherm Medical AG
    • SPD Swiss Precision Diagnostics GmbH
    • The Boots Company PLC
    • Alfa Scientific Designs, Inc.
    • Proov
    • Ro Wondfo
    • AdvaCare Pharma
    • Everly Health, Inc.
Product Code: FBI109709

Growth Factors of ovulation testing kits Market

The global ovulation testing kits market size was valued at USD 266.4 million in 2025 and is projected to grow from USD 282.9 million in 2026 to USD 489.7 million by 2034, exhibiting a CAGR of 7.10% during the forecast period (2026-2034). North America dominated the market with a 74.20% share in 2025, primarily due to the high prevalence of Polycystic Ovary Syndrome (PCOS), strong awareness regarding fertility health, and widespread adoption of at-home testing solutions.

Ovulation testing kits are diagnostic tools designed to help women track their menstrual cycle and determine their fertility window. These kits typically detect luteinizing hormone (LH) surge or progesterone metabolites, helping women plan pregnancy more effectively. They are widely used among women experiencing irregular ovulation, particularly those suffering from PCOS.

COVID-19 IMPACT

During the COVID-19 outbreak in 2020, the market experienced slow growth due to supply chain disruptions, limited product availability, and reduced visits to gynecologists. However, in the second half of 2020, demand rebounded significantly as consumers increasingly preferred home-based fertility monitoring solutions. This shift toward self-testing and telehealth-supported diagnostics positively influenced long-term market growth.

MARKET TRENDS

Increasing Focus on New Product Launches and Collaborations

Growing awareness regarding PCOS and fertility tracking has encouraged companies to introduce innovative products. Market players are increasingly launching digital and app-connected ovulation kits that offer accurate, quick, and easy-to-interpret results.

For instance, in May 2023, Fridababy, LLC launched a new line of fertility products, including an ovulation prediction test and ovulation & pregnancy tracking kits. Similarly, in July 2023, Proov collaborated with Quest Diagnostics Incorporated to expand access to Confirm PdG, an at-home fertility testing kit. Such initiatives are enhancing product availability and boosting global adoption.

MARKET GROWTH FACTORS

Increasing Prevalence of PCOS

Polycystic Ovary Syndrome (PCOS) is a leading hormonal disorder affecting reproductive-aged women, often causing irregular menstrual cycles and infertility. According to the World Health Organization (WHO) (June 2023), PCOS affects approximately 8-13% of women globally and is one of the leading causes of infertility.

In India, as per the National Center for Biotechnology Information (NCBI) (2022), the prevalence of PCOS was around 10% among women aged 15-45 years as per the Androgen Excess Society (AES), and 5.8% as per the National Institutes of Health (NIH). This rising prevalence is significantly driving demand for ovulation testing kits.

Additionally, ovulation kits offer high accuracy levels. According to Cloudnine Fertility (November 2022), ovulation prediction kits can be around 97% accurate, which further supports their adoption.

RESTRAINING FACTORS

Clinical Limitations and Risk of False Results

Despite their benefits, ovulation testing kits have certain limitations. According to an article published by Dotdash Meredith (June 2023), ovulation tests may provide inaccurate results when used alongside medications such as hormonal birth control, fertility drugs, or antibiotics containing tetracycline.

Moreover, while ovulation kits can detect LH surge with up to 99% effectiveness, they cannot confirm ovulation or guarantee pregnancy. Since these kits only track ovulation and not egg viability, their limitations may hinder broader adoption.

MARKET SEGMENTATION ANALYSIS

By Device Type

The market is segmented into digital devices, line indicator devices, and microscopic devices.

  • The digital devices segment is projected to hold 89.57% market share in 2026, driven by higher accuracy, faster results, reliability, and ease of use.
  • The line indicator devices segment is expected to record the fastest CAGR due to affordability and convenience for home use.
  • The microscopic devices segment is anticipated to grow steadily owing to reusability and long-term usability.

By Sample Type

Based on sample type, the market is segmented into blood, urine, and saliva.

  • The blood segment is expected to dominate with 89.15% share in 2026, attributed to higher accuracy and integration with mobile applications for result tracking.
  • The urine segment is anticipated to grow significantly due to increased product launches, such as Ro's urine-based LH detection kit launched in June 2020.

By End-User

The market is segmented into fertility centers, hospitals & clinics, and others.

  • The fertility centers segment is projected to lead with 57.72% share in 2026, supported by the rising number of fertility clinics globally.
  • The hospitals & clinics segment is expected to grow at a significant rate due to increasing patient preference for combined testing and treatment facilities.

REGIONAL INSIGHTS

North America

North America accounted for the largest market share in 2025 (74.20%). The regional market is estimated to reach USD 210.4 million in 2026, driven by high PCOS prevalence and strong awareness of fertility testing.

Europe

Europe holds a substantial market share due to the presence of key players such as Geratherm Medical AG and SPD Swiss Precision Diagnostics GmbH. The region benefits from advanced healthcare infrastructure and fertility treatment adoption.

Asia Pacific

Asia Pacific is projected to witness significant growth during the forecast period due to rising infertility cases in China and India, increasing awareness, and expanding access to digital health solutions.

Rest of the World

The market in other regions is expected to grow steadily due to the increasing penetration of global manufacturers into untapped markets.

KEY INDUSTRY PLAYERS

Major companies operating in the market include:

  • Piramal Pharma Ltd.
  • Geratherm Medical AG
  • SPD Swiss Precision Diagnostics GmbH
  • The Boots Company PLC
  • Proov
  • Ro
  • Wondfo
  • Everly Health, Inc.
  • Alfa Scientific Designs, Inc.
  • AdvaCare Pharma

These companies focus on mergers, acquisitions, partnerships, and product innovation to strengthen their market presence.

KEY INDUSTRY DEVELOPMENTS

  • July 2023: Proov signed a distribution agreement with 2SAN GLOBAL LIMITED to expand product distribution in the U.S.
  • May 2023: Fridababy launched new fertility product lines.
  • January 2022: Kindbody launched "Kind at Home" fertility test kits.
  • May 2021: Ro acquired Modern Fertility to expand fertility product offerings.

CONCLUSION

The global ovulation testing kits market is expected to grow from USD 266.4 million in 2025 to USD 489.7 million by 2034, rising at a CAGR of 7.10%. The market will expand to USD 282.9 million in 2026, driven by increasing PCOS prevalence, rising awareness about fertility health, and strong demand for home-based digital testing solutions. While limitations related to accuracy and medication interference remain challenges, ongoing product innovations, digital integration, and expanding fertility clinics are expected to sustain long-term market growth through 2034.

Segmentation By Device Type

  • Line Indicator Devices
  • Digital Devices
  • Microscopic Devices

By Sample Type

  • Urine
  • Blood
  • Saliva

By End-User

  • Hospitals & Clinics
  • Fertility Centers
  • Others

By Region

  • North America (By Device Type, Sample Type, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Device Type, Sample Type, End-user, and Country)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Device Type, Sample Type, End-user, and Country)
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia Pacific
  • Rest of the World (By Product, Sample Type, and End-user)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Infertility Among Women - by Key Countries/Sub-region, 2025
  • 4.2. New Product Launches
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.4. Impact of COVID-19 on the Market

5. Global Ovulation Testing Kits Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Device Type
    • 5.1.1. Line Indicator Devices
    • 5.1.2. Digital Devices
    • 5.1.3. Microscopic Devices
  • 5.2. Market Analysis, Insights and Forecast - By Sample Type
    • 5.2.1. Urine
    • 5.2.2. Blood
    • 5.2.3. Saliva
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals & Clinics
    • 5.3.2. Fertility Centers
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Rest of the World

6. North America Ovulation Testing Kits Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Device Type
    • 6.1.1. Line Indicator Devices
    • 6.1.2. Digital Devices
    • 6.1.3. Microscopic Devices
  • 6.2. Market Analysis, Insights and Forecast - By Sample Type
    • 6.2.1. Urine
    • 6.2.2. Blood
    • 6.2.3. Saliva
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospitals & Clinics
    • 6.3.2. Fertility Centers
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Ovulation Testing Kits Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Device Type
    • 7.1.1. Line Indicator Devices
    • 7.1.2. Digital Devices
    • 7.1.3. Microscopic Devices
  • 7.2. Market Analysis, Insights and Forecast - By Sample Type
    • 7.2.1. Urine
    • 7.2.2. Blood
    • 7.2.3. Saliva
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospitals & Clinics
    • 7.3.2. Fertility Centers
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. U.K.
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Rest of the Europe

8. Asia Pacific Ovulation Testing Kits Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Device Type
    • 8.1.1. Line Indicator Devices
    • 8.1.2. Digital Devices
    • 8.1.3. Microscopic Devices
  • 8.2. Market Analysis, Insights and Forecast - By Sample Type
    • 8.2.1. Urine
    • 8.2.2. Blood
    • 8.2.3. Saliva
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. Fertility Centers
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Rest of Asia Pacific

9. Rest of the World Ovulation Testing Kits Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Device Type
    • 9.1.1. Line Indicator Devices
    • 9.1.2. Digital Devices
    • 9.1.3. Microscopic Devices
  • 9.2. Market Analysis, Insights and Forecast - By Sample Type
    • 9.2.1. Urine
    • 9.2.2. Blood
    • 9.2.3. Saliva
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospitals & Clinics
    • 9.3.2. Fertility Centers
    • 9.3.3. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Piramal Pharma Ltd.
      • 10.2.1.1. Overview
      • 10.2.1.2. Products & services
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. Geratherm Medical AG
      • 10.2.2.1. Overview
      • 10.2.2.2. Products & services
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. SPD Swiss Precision Diagnostics GmbH
      • 10.2.3.1. Overview
      • 10.2.3.2. Products & services
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. The Boots Company PLC
      • 10.2.4.1. Overview
      • 10.2.4.2. Products & services
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. Alfa Scientific Designs, Inc.
      • 10.2.5.1. Overview
      • 10.2.5.2. Products & services
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. Proov
      • 10.2.6.1. Overview
      • 10.2.6.2. Products & services
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. Ro Wondfo
      • 10.2.7.1. Overview
      • 10.2.7.2. Products & services
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)
    • 10.2.8. AdvaCare Pharma
      • 10.2.8.1. Overview
      • 10.2.8.2. Products & services
      • 10.2.8.3. SWOT Analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. Financials (Based on Availability)
    • 10.2.9. Everly Health, Inc.
      • 10.2.9.1. Overview
      • 10.2.9.2. Products & services
      • 10.2.9.3. SWOT Analysis
      • 10.2.9.4. Recent Developments
      • 10.2.9.5. Strategies
      • 10.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Ovulation Testing Kits Market Revenue (USD million) Forecast, by Device Type, 2021-2034
  • Table 2: Global Ovulation Testing Kits Market Revenue (USD million) Forecast, by Sample Type, 2021-2034
  • Table 3: Global Ovulation Testing Kits Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 4: Global Ovulation Testing Kits Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 5: North America Ovulation Testing Kits Market Revenue (USD million) Forecast, by Device Type, 2021-2034
  • Table 6: North America Ovulation Testing Kits Market Revenue (USD million) Forecast, by Sample Type, 2021-2034
  • Table 7: North America Ovulation Testing Kits Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 8: North America Ovulation Testing Kits Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 9: Europe Ovulation Testing Kits Market Revenue (USD million) Forecast, by Device Type, 2021-2034
  • Table 10: Europe Ovulation Testing Kits Market Revenue (USD million) Forecast, by Sample Type, 2021-2034
  • Table 11: Europe Ovulation Testing Kits Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 12: Europe Ovulation Testing Kits Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Ovulation Testing Kits Market Revenue (USD million) Forecast, by Device Type, 2021-2034
  • Table 14: Asia Pacific Ovulation Testing Kits Market Revenue (USD million) Forecast, by Sample Type, 2021-2034
  • Table 15: Asia Pacific Ovulation Testing Kits Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 16: Asia Pacific Ovulation Testing Kits Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Rest of the World Ovulation Testing Kits Market Revenue (USD million) Forecast, by Device Type, 2021-2034
  • Table 18: Rest of the World Ovulation Testing Kits Market Revenue (USD million) Forecast, by Sample Type, 2021-2034
  • Table 19: Rest of the World Ovulation Testing Kits Market Revenue (USD million) Forecast, by End-user, 2021-2034

List of Figures

  • Figure 1: Global Ovulation Testing Kits Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Ovulation Testing Kits Market Value Share (%), by Device Type, 2025 & 2034
  • Figure 3: Global Ovulation Testing Kits Market Value Share (%), by Sample Type, 2025 & 2034
  • Figure 4: Global Ovulation Testing Kits Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Ovulation Testing Kits Market Value (USD million), by Region, 2025 & 2034
  • Figure 6: North America Ovulation Testing Kits Market Value (USD million), by Device Type, 2025 & 2034
  • Figure 7: North America Ovulation Testing Kits Market Value Share (%), by Device Type, 2025
  • Figure 8: North America Ovulation Testing Kits Market Value (USD million), by Sample Type, 2025 & 2034
  • Figure 9: North America Ovulation Testing Kits Market Value Share (%), by Sample Type, 2025
  • Figure 10: North America Ovulation Testing Kits Market Value (USD million), by End-user, 2025 & 2034
  • Figure 11: North America Ovulation Testing Kits Market Value Share (%), by End-user, 2025
  • Figure 12: North America Ovulation Testing Kits Market Value (USD million), By Country, 2025 & 2034
  • Figure 13: North America Ovulation Testing Kits Market Value Share (%), By Country, 2025
  • Figure 14: Europe Ovulation Testing Kits Market Value (USD million), by Device Type, 2025 & 2034
  • Figure 15: Europe Ovulation Testing Kits Market Value Share (%), by Device Type, 2025
  • Figure 16: Europe Ovulation Testing Kits Market Value (USD million), by Sample Type, 2025 & 2034
  • Figure 17: Europe Ovulation Testing Kits Market Value Share (%), by Sample Type, 2025
  • Figure 18: Europe Ovulation Testing Kits Market Value (USD million), by End-user, 2025 & 2034
  • Figure 19: Europe Ovulation Testing Kits Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Ovulation Testing Kits Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Ovulation Testing Kits Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Ovulation Testing Kits Market Value (USD million), by Device Type, 2025 & 2034
  • Figure 23: Asia Pacific Ovulation Testing Kits Market Value Share (%), by Device Type, 2025
  • Figure 24: Asia Pacific Ovulation Testing Kits Market Value (USD million), by Sample Type, 2025 & 2034
  • Figure 25: Asia Pacific Ovulation Testing Kits Market Value Share (%), by Sample Type, 2025
  • Figure 26: Asia Pacific Ovulation Testing Kits Market Value (USD million), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Ovulation Testing Kits Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Ovulation Testing Kits Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Ovulation Testing Kits Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Rest of the World Ovulation Testing Kits Market Value (USD million), by Device Type, 2025 & 2034
  • Figure 31: Rest of the World Ovulation Testing Kits Market Value Share (%), by Device Type, 2025
  • Figure 32: Rest of the World Ovulation Testing Kits Market Value (USD million), by Sample Type, 2025 & 2034
  • Figure 33: Rest of the World Ovulation Testing Kits Market Value Share (%), by Sample Type, 2025
  • Figure 34: Rest of the World Ovulation Testing Kits Market Value (USD million), by End-user, 2025 & 2034
  • Figure 35: Rest of the World Ovulation Testing Kits Market Value Share (%), by End-user, 2025
  • Figure 36: Global Ovulation Testing Kits Market Share (%), By Company, 2025